See more : Suzhou Yangtze New Materials Co., Ltd. (002652.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Trees Corporation (CANN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Trees Corporation, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Barrel Energy, Inc. (BRLL) Income Statement Analysis – Financial Results
- Shanghai Zhangjiang Hi-Tech Park Development Co., Ltd. (600895.SS) Income Statement Analysis – Financial Results
- Medipower (Overseas) Public Co. Limited (MDPR.TA) Income Statement Analysis – Financial Results
- ZONBONG LANDSCAPE Environmental Limited (1855.HK) Income Statement Analysis – Financial Results
- ASEC International Corporation (6113.TWO) Income Statement Analysis – Financial Results
Trees Corporation (CANN)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.treescann.com
About Trees Corporation
Trees Corporation provides products and services to the regulated cannabis industry and non-cannabis customers in the United States. The company operates through Retail and Cultivation segments. It operates a licensed 17,000 square foot light deprivation greenhouse cultivation facility; and a retail dispensary store in Englewood, Colorado, as well as two retail stores in Portland, Oregon. The company was formerly known as General Cannabis Corp. and changed its name to Trees Corporation in June 2022. Trees Corporation was incorporated in 2013 and is headquartered in Denver, Colorado.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 18.14M | 13.44M | 5.93M | 7.12M | 3.67M | 4.62M | 3.52M | 2.98M | 1.76M | 240.21K | 0.00 | 21.03K | 61.56K | 100.64K | 38.00K |
Cost of Revenue | 11.56M | 8.58M | 4.44M | 5.47M | 2.47M | 3.74M | 2.79M | 1.99M | 1.42M | 68.54K | 186.15K | 48.11K | 31.25K | 28.19K | 7.44K |
Gross Profit | 6.57M | 4.87M | 1.49M | 1.65M | 1.20M | 879.76K | 736.37K | 988.48K | 339.95K | 171.67K | -186.15K | -27.08K | 30.31K | 72.45K | 30.57K |
Gross Profit Ratio | 36.24% | 36.20% | 25.10% | 23.21% | 32.71% | 19.05% | 20.91% | 33.15% | 19.28% | 71.47% | 0.00% | -128.75% | 49.24% | 71.99% | 80.43% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 1.38M | 7.71M | 4.00M | 7.50M | 9.95M | 12.14M | 7.44M | 6.31M | 7.30M | 2.64M | 776.00K | 40.72K | 51.47K | 18.34K | 63.31K |
Selling & Marketing | 8.29M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 9.67M | 7.71M | 4.00M | 7.50M | 9.95M | 12.14M | 7.44M | 6.31M | 7.30M | 2.64M | 776.00K | 40.72K | 51.47K | 18.34K | 63.31K |
Other Expenses | 874.41K | 331.38K | 500.57K | 215.46K | 115.70K | 149.50K | 125.91K | 394.22K | 282.83K | 66.26K | 0.00 | -59.25K | 38.96K | 0.00 | 0.00 |
Operating Expenses | 10.55M | 8.04M | 4.50M | 7.72M | 10.06M | 12.29M | 7.56M | 6.70M | 7.58M | 2.71M | 1.03M | -18.53K | 90.43K | 18.34K | 63.31K |
Cost & Expenses | 22.11M | 16.62M | 8.94M | 13.19M | 12.53M | 16.03M | 10.35M | 8.69M | 9.01M | 2.78M | 1.22M | 29.58K | 121.67K | 46.54K | 70.75K |
Interest Income | 0.00 | 234.38K | 1.31M | 748.78K | 2.37M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 18.00 | 110.00 | 22.00 | 89.00 |
Interest Expense | 2.58M | 2.80M | 1.31M | 748.78K | 2.37M | 4.56M | 1.37M | 6.29M | 1.75M | 1.00M | 0.00 | 18.00 | 110.00 | 22.00 | 89.00 |
Depreciation & Amortization | 2.68M | 1.60M | 991.20K | 485.91K | 115.70K | 62.44K | 125.91K | 394.22K | 282.83K | 66.26K | 962.15K | 23.58K | -1.32K | 107.07K | -250.00 |
EBITDA | -1.64M | -5.37M | -6.12M | -6.19M | -11.33M | -11.51M | -6.73M | -8.83M | -6.96M | -5.86M | 0.00 | -8.55K | -61.43K | 570.00 | -32.74K |
EBITDA Ratio | -9.03% | -21.21% | -39.98% | -80.76% | -236.35% | -247.68% | -190.22% | -178.35% | -394.82% | -1,028.07% | 0.00% | 15.40% | -99.78% | 106.96% | -86.82% |
Operating Income | -3.97M | -3.17M | -3.01M | -6.07M | -8.86M | -11.41M | -7.05M | -7.06M | -7.24M | -2.54M | -962.15K | -20.34K | -60.11K | 570.00 | -32.74K |
Operating Income Ratio | -21.91% | -23.61% | -50.83% | -85.19% | -241.70% | -246.97% | -200.09% | -236.65% | -410.86% | -1,055.65% | 0.00% | -96.72% | -97.64% | 0.57% | -86.16% |
Total Other Income/Expenses | -2.92M | -6.10M | -5.41M | -1.55M | -4.95M | -5.56M | -1.17M | -3.11M | -1.54M | -4.39M | -260.00K | 18.00 | 1.43K | 22.00 | 339.00 |
Income Before Tax | -6.89M | -9.28M | -8.43M | -7.62M | -10.79M | -16.97M | -8.22M | -32.80M | -8.79M | -6.93M | -1.22M | -20.32K | -58.68K | 592.00 | -32.41K |
Income Before Tax Ratio | -38.01% | -68.99% | -142.18% | -107.01% | -294.22% | -367.50% | -233.41% | -1,099.93% | -498.38% | -2,885.08% | 0.00% | -96.63% | -95.32% | 0.59% | -85.27% |
Income Tax Expense | 187.85K | 204.92K | 1.89M | 907.60K | 4.04M | -1.01M | 1.37M | 6.29M | 1.75M | 1.00M | -260.00K | -11.81K | -110.00 | 1.32K | -89.00 |
Net Income | -7.08M | -9.48M | -10.31M | -8.53M | -14.83M | -16.97M | -8.22M | -32.80M | -8.79M | -6.93M | -1.22M | -20.32K | -58.68K | -726.00 | -32.41K |
Net Income Ratio | -39.05% | -70.52% | -173.99% | -119.75% | -404.43% | -367.50% | -233.41% | -1,099.93% | -498.38% | -2,885.08% | 0.00% | -96.63% | -95.32% | -0.72% | -85.27% |
EPS | -0.06 | -0.07 | -0.15 | -0.17 | -0.39 | -0.49 | -0.40 | -2.12 | -0.63 | -0.51 | -0.09 | 0.00 | -0.01 | 0.00 | 0.00 |
EPS Diluted | -0.06 | -0.07 | -0.15 | -0.17 | -0.39 | -0.49 | -0.40 | -2.12 | -0.63 | -0.51 | -0.09 | 0.00 | -0.01 | 0.00 | 0.00 |
Weighted Avg Shares Out | 117.20M | 138.96M | 69.54M | 50.90M | 38.11M | 34.94M | 20.47M | 15.49M | 14.02M | 13.46M | 13.46M | 9.72M | 9.71M | 9.50M | 8.75M |
Weighted Avg Shares Out (Dil) | 117.20M | 138.96M | 69.54M | 50.90M | 38.11M | 34.94M | 20.47M | 15.49M | 14.02M | 13.46M | 13.46M | 9.72M | 9.71M | 9.50M | 8.75M |
CORRECTING and REPLACING Heritage Cannabis Executes Term Sheet with Merida Capital Holdings to Support Entry into the Missouri Market in Relationship with 3Fifteen Primo Cannabis
TREES Announces Closing of Series A Convertible Preferred Equity Offering; Convertible at $1.00 Per Share
Heritage Launches Private Label Program with High Tide Inc.
TREES Announces Key Promotions and Leadership Roles
General Cannabis Announces Closing of the Acquisition of TREES Englewood and Corporate Name Change to “TREES”; Board of Director Added
General Cannabis Submits Change of Ownership License to Colorado's Marijuana Enforcement Division (MED) for Englewood Dispensary Location
General Cannabis to Create Retail Footprint by Acquiring Trees Dispensaries
Cannabis Legalization Isn't A Threat, It's An Opportunity (Podcast Transcript)
Cannabis Movers & Shakers: TILT, BRNT, ECGI, Alcanna, WeedMD, Mind Cure, The FLowr Corporation, VIVO, Cannabiz, Team Hytiva
Cannabis Legalization Isn't A Threat, It's An Opportunity (Podcast)
Source: https://incomestatements.info
Category: Stock Reports